129 research outputs found
Seizure's outcome after cortical resections including the face and tongue rolandic areas in patients with refractory epilepsy and normal MRI submitted to subdural grids' implantation
Effects of tendon transfer to restore index finger abduction for severe cubital tunnel syndrome
Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival
A genome scan for milk production traits in dairy goats reveals two new mutations in <i>Dgat1</i> reducing milk fat content
The quantity of milk and milk fat and proteins are particularly important traits in dairy livestock.
However, little is known about the regions of the genome that influence these traits in goats. We
conducted a genome wide association study in French goats and identified 109 regions associated
with dairy traits. For a major region on chromosome 14 closely associated with fat content, the
Diacylglycerol O-Acyltransferase 1 (DGAT1) gene turned out to be a functional and positional candidate
gene. The caprine reference sequence of this gene was completed and 29 polymorphisms were found in
the gene sequence, including two novel exonic mutations: R251L and R396W, leading to substitutions
in the protein sequence. The R251L mutation was found in the Saanen breed at a frequency of 3.5% and
the R396W mutation both in the Saanen and Alpine breeds at a frequencies of 13% and 7% respectively.
The R396W mutation explained 46% of the genetic variance of the trait, and the R251L mutation 6%.
Both mutations were associated with a notable decrease in milk fat content. Their causality was then
demonstrated by a functional test. These results provide new knowledge on the genetic basis of milk
synthesis and will help improve the management of the French dairy goat breeding program
Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance.
Pharmacokinetic/pharmacodynamic (PKPD) modeling is important in the design and conduct of clinical pharmacology research in children. During drug development, PKPD modeling and simulation should underpin rational trial design and facilitate extrapolation to investigate efficacy and safety. The application of PKPD modeling to optimize dosing recommendations and therapeutic drug monitoring is also increasing, and PKPD model-based dose individualization will become a core feature of personalized medicine. Following extensive progress on pediatric PK modeling, a greater emphasis now needs to be placed on PD modeling to understand age-related changes in drug effects. This paper discusses the principles of PKPD modeling in the context of pediatric drug development, summarizing how important PK parameters, such as clearance (CL), are scaled with size and age, and highlights a standardized method for CL scaling in children. One standard scaling method would facilitate comparison of PK parameters across multiple studies, thus increasing the utility of existing PK models and facilitating optimal design of new studies
Cervical lymph node metastasis in adenoid cystic carcinoma of the larynx: a collective international review
Adenoid cystic carcinoma (AdCC) of the head and neck is a well-recognized pathologic entity that rarely occurs in the larynx. Although the 5-year locoregional control rates are high, distant metastasis has a tendency to appear more than 5 years post treatment. Because AdCC of the larynx is uncommon, it is difficult to standardize a treatment protocol. One of the controversial points is the decision whether or not to perform an elective neck dissection on these patients. Because there is contradictory information about this issue, we have critically reviewed the literature from 1912 to 2015 on all reported cases of AdCC of the larynx in order to clarify this issue. During the most recent period of our review (1991-2015) with a more exact diagnosis of the tumor histology, 142 cases were observed of AdCC of the larynx, of which 91 patients had data pertaining to lymph node status. Eleven of the 91 patients (12.1%) had nodal metastasis and, based on this low proportion of patients, routine elective neck dissection is therefore not recommended
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
To identify common alleles associated with different histotypes of epithelial ovarian cancer (EOC), we pooled data from multiple genome-wide genotyping projects totaling 25,509 EOC cases and 40,941 controls. We identified nine new susceptibility loci for different EOC histotypes: six for serous EOC histotypes (3q28, 4q32.3, 8q21.11, 10q24.33, 18q11.2 and 22q12.1), two for mucinous EOC (3q22.3 and 9q31.1) and one for endometrioid EOC (5q12.3). We then performed meta-analysis on the results for high-grade serous ovarian cancer with the results from analysis of 31,448 BRCA1 and BRCA2 mutation carriers, including 3,887 mutation carriers with EOC. This identified three additional susceptibility loci at 2q13, 8q24.1 and 12q24.31. Integrated analyses of genes and regulatory biofeatures at each locus predicted candidate susceptibility genes, including OBFC1, a new candidate susceptibility gene for low-grade and borderline serous EOC
- …